Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Gary S, Gottesman"'
Autor:
Farhan Chowdry, Kelsey M. Miller, Ersan Altun, Sara E. Wobker, Gary S. Gottesman, Hikmat Al-Ahmadie, Tracy L. Rose, Eric M. Wallen, Matthew I. Milowsky
Publikováno v:
Urology Case Reports, Vol 54, Iss , Pp 102710- (2024)
We present the case of a patient with X-Linked Hypophosphatemia (XLH) and an inflammatory myofibroblastic tumor (IMT) of the bladder which prompted further investigation into the possible relationship between XLH and IMT i.e. a case of Occam's Razor
Externí odkaz:
https://doaj.org/article/34c7d4f1164a409daa648507933f99b3
Autor:
Kathryn McCrystal Dahir, Margo Black, Gary S Gottesman, Erik A Imel, Steven Mumm, Cindy M Nichols, Michael P Whyte
Publikováno v:
JBMR Plus, Vol 6, Iss 12, Pp n/a-n/a (2022)
ABSTRACT Inactivating mutations of the gene coding for phosphate‐regulating endopeptidase homolog X‐linked (PHEX) cause X‐linked hypophosphatemia (XLH). A novel PHEX variant, c.*231A>G; exon 13–15 duplication, has emerged as a common cause of
Externí odkaz:
https://doaj.org/article/6ada1b7fc5a14c7ea4fcadd28a3ccbf2
Autor:
Erik A Imel, Francis H Glorieux, Michael P Whyte, Anthony A Portale, Craig F Munns, Ola Nilsson, Jill H Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S Gottesman, Andrew Biggin, Farzana Perwad, Angel Chen, Mary Scott Roberts, Leanne M Ward
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
Context In an open-label, randomized, controlled, phase 3 trial in 61 children aged 1 to 12 years with X-linked hypophosphatemia (XLH), burosumab improved rickets vs continuing conventional therapy with active vitamin D and phosphate. Objective We co
Autor:
Caleb W. Grote, Jeffrey J. Nepple, Perry L. Schoenecker, Gary S. Gottesman, J. Eric Gordon, Mark L. Miller
Publikováno v:
Journal of Pediatric Orthopaedics.
Autor:
null Kathryn McCrystal Dahir, null Margo Black, null Gary S. Gottesman, null Erik A. Imel, null Steven Mumm, null Cindy M. Nichols, null Michael P. Whyte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8520cd5b5b74d8576aee2882bea9747f
https://doi.org/10.1002/jbm4.10692/v2/response1
https://doi.org/10.1002/jbm4.10692/v2/response1
Autor:
Andrew Hornback, Wenqi Shi, Felipe O. Giuste, Yuanda Zhu, Ashley M. Carpenter, Coleman Hilton, Vinieth N. Bijanki, Hiram Stahl, Gary S. Gottesman, Chad Purnell, Henry J. Iwinski, J. Michael Wattenbarger, May D. Wang
Publikováno v:
Proceedings of the 13th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics.
Autor:
Leanne M Ward, Francis H Glorieux, Michael P Whyte, Craig F Munns, Anthony A Portale, Wolfgang Högler, Jill H Simmons, Gary S Gottesman, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Ola Nilsson, Meng Mao, Angel Chen, Alison Skrinar, Mary Scott Roberts, Erik A Imel
Publikováno v:
The Journal of clinical endocrinology and metabolism. 107(8)
Context Younger age at treatment onset with conventional therapy (phosphate salts and active vitamin D; Pi/D) is associated with improved growth and skeletal outcomes in children with X-linked hypophosphatemia (XLH). The effect of age on burosumab ef
Autor:
Hae Il Cheong, Meng Mao, Ola Nilsson, Alison Skrinar, Gary S. Gottesman, Wolfgang Högler, Javier San Martin, Hiroyuki Tanaka, Noriyuki Namba, Raja Padidela, Francis H. Glorieux, Michael P. Whyte, Koji Muroya, Craig F Munns, Chao-Yin Chen, Andrew Biggin, Erik A. Imel, Etienne Sochett, Leanne Ward, Anthony A. Portale, Jill H. Simmons, Farzana Perwad, Pisit Pitukcheewanont
Publikováno v:
The Lancet. 393:2416-2427
X-linked hypophosphataemia in children is characterised by elevated serum concentrations of fibroblast growth factor 23 (FGF23), hypophosphataemia, rickets, lower extremity bowing, and growth impairment. We compared the efficacy and safety of continu
Autor:
Michael P, Whyte, Jennifer D, May, William H, McAlister, Katherine, Burgener, Samuel R, Cortez, Raymond, Kreienkamp, Olivia, Castro, Rachel, Verzola, Ana Solis, Zavala, Christopher C, McPherson, Gary S, Gottesman, Karen L, Ericson, Stephen P, Coburn, Ana Maria, Arbelaez
Publikováno v:
Bone. 150
Pyridoxal 5'-phosphate (PLP), the principal circulating form of vitamin B
Autor:
Annabel Nixon, Ola Nilsson, Farzana Perwad, Etienne Sochett, Raja Padidela, Wei Sun, Anthony A. Portale, Craig F Munns, Francis H. Glorieux, Andrew Biggin, Michael P. Whyte, Hiroyuki Tanaka, Noriyuki Namba, Wolfgang Högler, Pisit Pitukcheewanont, Erik A. Imel, Hae Il Cheong, Alison Skrinar, Angel Chen, Leanne M Ward, Gary S. Gottesman, Angela Williams, Koji Muroya, Jill H. Simmons
Publikováno v:
Calcified Tissue International
Changing to burosumab, a monoclonal antibody targeting fibroblast growth factor 23, significantly improved phosphorus homeostasis, rickets, lower-extremity deformities, mobility, and growth versus continuing oral phosphate and active vitamin D (conve